In vitro activity of ceftaroline against staphylococci from prosthetic joint infection

Kyung Hwa Park, Kerryl E. Greenwood-Quaintance, Robin Patel

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We tested the in vitro activity of ceftaroline by Etest against staphylococci recovered from patients with prosthetic joint infection, including 97 Staphylococcus aureus isolates (36%, oxacillin resistant) and 74 Staphylococcus epidermidis isolates (74%, oxacillin resistant). Ceftaroline inhibited all staphylococci at ≤0.5μg/mL. The ceftaroline MIC90/50 values for methicillin-susceptible S. aureus, methicillin-susceptible S. epidermidis, methicillin-resistant S. aureus, and methicillin-resistant S. epidermidis were 0.19/0.125, 0.094/0.047, 0.5/0.38, and 0.38/0.19μg/mL, respectively. Based on these in vitro findings, ceftaroline should be further evaluated as a potential therapeutic option for the treatment of prosthetic joint infection caused by methicillin-susceptible and methicillin-resistant S. aureus and S. epidermidis.

Original languageEnglish (US)
Pages (from-to)141-143
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume84
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Staphylococcus epidermidis
Staphylococcus
Methicillin
Joints
Oxacillin
Methicillin-Resistant Staphylococcus aureus
Infection
Staphylococcus aureus
Disk Diffusion Antimicrobial Tests
Methicillin Resistance
In Vitro Techniques
T 91825
Therapeutics

Keywords

  • Ceftaroline
  • Prosthetic joint infection
  • Staphylococcus aureus
  • Staphylococcus epidermidis

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

In vitro activity of ceftaroline against staphylococci from prosthetic joint infection. / Park, Kyung Hwa; Greenwood-Quaintance, Kerryl E.; Patel, Robin.

In: Diagnostic Microbiology and Infectious Disease, Vol. 84, No. 2, 01.02.2016, p. 141-143.

Research output: Contribution to journalArticle

@article{bcc0ed73428049ceaada8905344bd3af,
title = "In vitro activity of ceftaroline against staphylococci from prosthetic joint infection",
abstract = "We tested the in vitro activity of ceftaroline by Etest against staphylococci recovered from patients with prosthetic joint infection, including 97 Staphylococcus aureus isolates (36{\%}, oxacillin resistant) and 74 Staphylococcus epidermidis isolates (74{\%}, oxacillin resistant). Ceftaroline inhibited all staphylococci at ≤0.5μg/mL. The ceftaroline MIC90/50 values for methicillin-susceptible S. aureus, methicillin-susceptible S. epidermidis, methicillin-resistant S. aureus, and methicillin-resistant S. epidermidis were 0.19/0.125, 0.094/0.047, 0.5/0.38, and 0.38/0.19μg/mL, respectively. Based on these in vitro findings, ceftaroline should be further evaluated as a potential therapeutic option for the treatment of prosthetic joint infection caused by methicillin-susceptible and methicillin-resistant S. aureus and S. epidermidis.",
keywords = "Ceftaroline, Prosthetic joint infection, Staphylococcus aureus, Staphylococcus epidermidis",
author = "Park, {Kyung Hwa} and Greenwood-Quaintance, {Kerryl E.} and Robin Patel",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.diagmicrobio.2015.10.012",
language = "English (US)",
volume = "84",
pages = "141--143",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - In vitro activity of ceftaroline against staphylococci from prosthetic joint infection

AU - Park, Kyung Hwa

AU - Greenwood-Quaintance, Kerryl E.

AU - Patel, Robin

PY - 2016/2/1

Y1 - 2016/2/1

N2 - We tested the in vitro activity of ceftaroline by Etest against staphylococci recovered from patients with prosthetic joint infection, including 97 Staphylococcus aureus isolates (36%, oxacillin resistant) and 74 Staphylococcus epidermidis isolates (74%, oxacillin resistant). Ceftaroline inhibited all staphylococci at ≤0.5μg/mL. The ceftaroline MIC90/50 values for methicillin-susceptible S. aureus, methicillin-susceptible S. epidermidis, methicillin-resistant S. aureus, and methicillin-resistant S. epidermidis were 0.19/0.125, 0.094/0.047, 0.5/0.38, and 0.38/0.19μg/mL, respectively. Based on these in vitro findings, ceftaroline should be further evaluated as a potential therapeutic option for the treatment of prosthetic joint infection caused by methicillin-susceptible and methicillin-resistant S. aureus and S. epidermidis.

AB - We tested the in vitro activity of ceftaroline by Etest against staphylococci recovered from patients with prosthetic joint infection, including 97 Staphylococcus aureus isolates (36%, oxacillin resistant) and 74 Staphylococcus epidermidis isolates (74%, oxacillin resistant). Ceftaroline inhibited all staphylococci at ≤0.5μg/mL. The ceftaroline MIC90/50 values for methicillin-susceptible S. aureus, methicillin-susceptible S. epidermidis, methicillin-resistant S. aureus, and methicillin-resistant S. epidermidis were 0.19/0.125, 0.094/0.047, 0.5/0.38, and 0.38/0.19μg/mL, respectively. Based on these in vitro findings, ceftaroline should be further evaluated as a potential therapeutic option for the treatment of prosthetic joint infection caused by methicillin-susceptible and methicillin-resistant S. aureus and S. epidermidis.

KW - Ceftaroline

KW - Prosthetic joint infection

KW - Staphylococcus aureus

KW - Staphylococcus epidermidis

UR - http://www.scopus.com/inward/record.url?scp=84954402551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954402551&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2015.10.012

DO - 10.1016/j.diagmicrobio.2015.10.012

M3 - Article

C2 - 26602948

AN - SCOPUS:84954402551

VL - 84

SP - 141

EP - 143

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 2

ER -